AUS
NZ
UK
CA
USA
IND
Health
Siga Technologies (NASDAQ:SIGA) Nasdaq Top 100 Biomedical Strategy
January 22, 2026 12:00 AM PST| By Anmol KhazanchiSIGA Technologies (NASDAQ:SIGA) develops and commercializes medical countermeasures for public health emergencies and biological threats, appearing in broader market discussions that include the nasdaq top 100.
Lexicon Pharmaceuticals (NASDAQ:LXRX) Aligns Research With Genetics
January 22, 2026 12:00 AM PST| By Anmol KhazanchiLexicon Pharmaceuticals (NASDAQ:LXRX) applies genome biology and large-scale gene research to identify therapeutic targets, advancing novel medicines through structured preclinical and clinical development programs.
Annexon Inc (NASDAQ:ANNX) Advances Complement Biology Platform
January 22, 2026 12:00 AM PST| By Anmol KhazanchiAnnexon Inc (NASDAQ:ANNX) focuses on complement pathway inhibition to address neurodegenerative and neuroimmune disorders, advancing clinical-stage therapies targeting immune-mediated neurological damage.
Doximity (NASDAQ:DOCS) Strengthens Professional Medical Networking
January 21, 2026 12:00 AM PST| By Anmol KhazanchiDoximity (NASDAQ:DOCS) operates the leading professional medical network in the US, enabling physicians and clinicians to collaborate, access clinical news, and communicate securely through a digital platform.
Harrow Health (NASDAQ:HROW) Expanding Clinical Reach In Ophthalmology
January 21, 2026 12:00 AM PST| By Anmol KhazanchiHarrow Health (NASDAQ:HROW) operates as a commercial-stage biopharmaceutical company focused on ophthalmic therapeutics and diagnostics, delivering proprietary, generic, and branded products for ocular conditions.
TG Therapeutics Inc (NASDAQ:TGTX) Nasdaq 100 Etf Biotech Structure
January 20, 2026 12:00 AM PST| By Anmol KhazanchiTG Therapeutics develops targeted therapies for hematological and autoimmune conditions, appearing in broader biotech conversations where the nasdaq 100 etf is mentioned within market-level analysis.
Axsome Therapeutics (NASDAQ:AXSM) Appears In Nasdaq Today CNS Discussions
January 20, 2026 12:00 AM PST| By Anmol KhazanchiAxsome Therapeutics develops novel CNS therapies targeting depression, migraine, narcolepsy, and fibromyalgia, appearing in broader biopharmaceutical discussions shaped by movements linked to nasdaq today.
HUTCHMED Ltd. (NASDAQ:HCM) Strengthens End-to-End Biopharma Model
January 20, 2026 12:00 AM PST| By Anmol KhazanchiHUTCHMED is a fully integrated biopharmaceutical company developing targeted therapies and immunotherapies, combining discovery research, clinical development, manufacturing, and commercialization across multiple disease areas.
Merck & Co., Inc. (NYSE:MRK) S&P 500 Fund Healthcare Scale
January 20, 2026 12:00 AM PST| By Anmol KhazanchiMerck & Co. (NYSE:MRK) supports global healthcare through medicines, vaccines, biologics, and animal health products, appearing in broader market discussions that include the s&p 500 fund.
ResMed Inc (NYSE:RMD) S&P 500 Chart Maps Long-Term Medical Presence
January 19, 2026 12:00 AM PST| By Anmol KhazanchiResMed (NYSE:RMD) advances sleep and respiratory care through medical devices and cloud-based solutions, appearing in broader healthcare discussions where the s&p 500 chart is commonly cited.
Agilent Technologies, Inc. (NYSE:A) S&P 500 Today Global Lab Support
January 19, 2026 12:00 AM PST| By Anmol KhazanchiAgilent Technologies delivers scientific instruments, software, and laboratory services worldwide, appearing in broader market discussions shaped by activity associated with s&p 500 today.
Edwards Lifesciences (NYSE:EW) S&P 500 Index Medical Device Presence
January 19, 2026 12:00 AM PST| By Anmol KhazanchiEdwards Lifesciences advances structural heart disease treatment through transcatheter and surgical valve technologies, appearing in broader healthcare discussions shaped by the s&p 500 index.
Johnson & Johnson (NYSE:JNJ) Dow Jones Index Medical Technology Reach
January 19, 2026 12:00 AM PST| By Anmol KhazanchiJohnson & Johnson operates as a global healthcare organization across pharmaceuticals and medical devices, remaining visible in broad financial discussions where the dow jones index is commonly cited.
Universal Health Services (NYSE:UHS) Russell 1000 Healthcare Scope
January 19, 2026 12:00 AM PST| By Anmol KhazanchiUniversal Health Services (NYSE:UHS) delivers acute and behavioral healthcare services across the United States, maintaining visibility in market discussions where the Russell 1000 includes diversified healthcare providers.
Liquidia Corporation (NASDAQ:LQDA) Builds Platform-Driven Biopharma
January 19, 2026 12:00 AM PST| By Anmol KhazanchiLiquidia Technologies (NASDAQ:LQDA) is a clinical-stage biopharmaceutical company using its PRINT® platform to engineer precisely designed drug particles aimed at improving targeted delivery and therapeutic performance.
Gilead Sciences (NASDAQ:GILD) Nasdaq Futures Spotlight Biopharma Scale
January 19, 2026 12:00 AM PST| By Anmol KhazanchiGilead Sciences (NASDAQ:GILD) maintains a strong global presence across antiviral, oncology, and cell therapy research, appearing in broader market discussions where nasdaq futures frame sector-wide activity.
Zimmer Biomet (NYSE:ZBH) S&P 500 Chart Reflects Medical Tech Scale
January 17, 2026 12:00 AM PST| By Anmol KhazanchiZimmer Biomet (NYSE:ZBH) supports global musculoskeletal healthcare through implants and surgical solutions, appearing in wider market discussions where the s&p 500 chart is part of overall financial dialogue.
Simulations Plus (NASDAQ:SLP) Nasdaq Composite Modeling-Driven Research
January 16, 2026 12:00 AM PST| By Anmol KhazanchiSimulations Plus (NASDAQ:SLP) supports pharmaceutical and biotechnology research through advanced modeling and simulation platforms, appearing in broader technology and healthcare discussions shaped by the nasdaq composite.
STAAR Surgical Company (NASDAQ:STAA) Nasdaq Composite Vision Innovation
January 16, 2026 12:00 AM PST| By Anmol KhazanchiSTAAR Surgical Company develops implantable Collamer lenses for vision correction, supporting ophthalmic care globally and appearing in healthcare discussions linked to the nasdaq composite.
Inhibrx Biosciences (NASDAQ:INBX) Nasdaq Futures Science-Driven Path
January 16, 2026 12:00 AM PST| By Anmol KhazanchiInhibrx focuses on next-generation protein therapeutics using advanced engineering platforms, maintaining visibility in biotechnology discussions where nasdaq futures often frame broader market and innovation themes.
